Innovative Cloud Solutions for Drug Safety, Data & Analytics, Regulatory and Medical Affairs.
Innovative Cloud Solutions for Drug Safety, Data & Analytics, Regulatory and Medical Affairs.
Core offering: LifeSphere — a SaaS platform for Safety, Regulatory, Quality, and Medical Affairs
AI capability: LifeSphere NavaX — next‑gen cognitive/GenAI engine (launched late 2023)
Customers: Serves 220+ global life sciences companies, CROs, and government health authorities
Ownership: Majority-owned by Nordic Capital since 2019; Nordic Capital increased ownership in 2021
Headquarters: U.S. headquarters relocated to Waltham, Massachusetts (Boston area) in 2023
Drug development R&D compliance and workflows, including pharmacovigilance (adverse event management), regulatory submissions, quality, and medical affairs.
Life sciences software
Nordic Capital acquired a majority stake in ArisGlobal.
Private equity financing recorded (amount not publicly disclosed).
Nordic Capital acquired additional shareholding from the founding Abbhi family.
“Nordic Capital is the primary disclosed majority owner since 2019 and increased its ownership position in 2021.”